Pneumonia vaccine study for healthy infants
Part of Infections clinical trials.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 6 and 8 weeks old.
- Your baby weighs at least 3 kilograms (about 6.6 pounds) at the start.
- Your baby has no serious health problems and is generally healthy.
- You can bring your baby to all study visits and follow instructions.
- You provide written permission for your baby to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This study tests a new pneumonia vaccine in healthy children to see if it is safe and works well. It may help protect your child from serious infections caused by the bacteria that lead to pneumonia.
This trial tests a 13-valent pneumococcal conjugate vaccine to prevent pneumonia and serious infections caused by pneumococcus bacteria. It may be a good option if your child has never had a pneumococcal vaccine before.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This trial tests a new pneumococcal vaccine for babies around 2 months old. It aims to prevent serious infections like pneumonia and meningitis, and may offer protection against more strains than current vaccines.
Hear when a new Pneumococcal Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.